Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
about
Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study.Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618.Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group Phase II study.Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neckChemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight casesDocetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neckHigher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.The role of chemotherapy in the management of patients with head and neck cancer.Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas.Head and neck squamous cell carcinoma: optimizing the therapeutic index.Taxanes in head and neck cancer.Docetaxel-associated epiphora.Docetaxel in the management of patients with head and neck squamous cell carcinoma.Induction chemotherapy of docetaxel and Cisplatin for the elderly patients with squamous cell carcinoma of the head and neck.Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck.Update on role of chemotherapy in head and neck squamous cell cancer.Reirradiation for recurrent head and neck cancer.Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study.Optimization of parameters for preparation of docetaxel-loaded PLGA nanoparticles by nanoprecipitation method.Docetaxel shows radiosensitization in human hepatocellular carcinoma cells.Enhanced Bax in oral SCC in relation to antitumor effects of chemotherapy.Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis.Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study.Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism.Neoadjuvant docetaxel and cisplatin chemotherapy followed by local irradiation is highly active on locoregionally advanced squamous cell carcinoma of the head and neck.Topoisomerase expression in oral squamous cell carcinoma: relationship with cancer stem cells profiles and lymph node metastasis.Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas.RASSF1A and ERCC1 expression levels might be predictive of prognosis in advanced, recurrent, and metastatic squamous cell carcinoma of the head and neck treated with docetaxel and cisplatin.Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma.
P2860
Q33362114-AD1BC233-DE41-4381-B7C4-5EDAE1EC4100Q33387184-D9D389A0-52FA-4967-8714-39A1EF01AFF8Q33436548-AAA114A5-EAFE-4A04-A706-A25EA1DDC1DAQ33941497-5BB3B1AF-1107-48FF-B2F5-E9D0DC03FDE3Q34631855-6236D6EA-994A-49B9-9900-DEF361A4AB5DQ34742875-B5A3CCA3-0654-41C8-84C4-6E682C5DF5AFQ34946913-E55CF224-8C3A-41C0-9499-26408E01ED5EQ35056376-30A42A97-385D-452C-A4F2-C0D137B2606EQ35462692-B9CE1063-522C-4637-8325-2595572D6C72Q35882999-899140FD-7A6A-4F2F-B137-A297EFAC6AC8Q35986419-F41A0B60-4CB3-41BB-8C40-9BA6AB60A945Q36022400-1D17523C-F2D5-4166-BA8A-8578B4F08F27Q36185629-1A303D34-8B65-46DC-A595-B0F9EABC0E23Q36429649-4CED0D69-FFFB-4A80-BA9C-183388083EEBQ36484970-961BD2FA-13BA-44AE-80D5-7D84F1C13978Q37202758-51939A57-A94E-4275-BFD8-BD14A8AEA768Q37336466-277DB845-CAE5-404E-9AD7-C06B2DCA942DQ37870929-3008AAAA-BDCB-4893-AA1F-7BC2748E9BF9Q38038836-4974CFBD-EC69-49A3-B3F5-E8A4A667928EQ38055496-B5D28866-F1D3-4947-91F2-4F056B392D5DQ39012243-3D089F4D-782D-4F4A-BDD4-082884BBC22AQ39329443-722810D8-87EA-427E-B4E6-8F2F36B54C1DQ40420500-2377606A-CCAE-4D31-B3E2-13FA20B5DCBFQ40473208-86B0E38B-0270-40FC-82C5-FD5F6A06623DQ41141076-F0B6EBA9-C112-4787-99FC-0EC247821606Q41986750-9FA1EEEB-6918-4719-B6A4-EEA77DA0B7D9Q43906898-4755AE06-D86D-45F5-8283-AE1320B3A3E5Q45010010-7A2BEA9A-32EB-4986-A04D-5A171D239EB3Q46959241-936FF3CA-F81C-409E-9B5D-0B9171117BDFQ47657563-6F69B5F3-090F-4856-8191-628602AC31AAQ49680136-968196AF-08B4-4C8B-A4D4-A8D1B2EC345BQ53134485-85CF08C4-B039-446B-B85F-72D95942D8A2Q55322325-EF9622EF-9580-4E9C-970D-B3E0C47294DC
P2860
Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Phase II Trial of docetaxel an ...... arcinoma of the head and neck.
@en
type
label
Phase II Trial of docetaxel an ...... arcinoma of the head and neck.
@en
prefLabel
Phase II Trial of docetaxel an ...... arcinoma of the head and neck.
@en
P2093
P356
P1476
Phase II Trial of docetaxel an ...... arcinoma of the head and neck.
@en
P2093
Arlene A Forastiere
Barbara A Murphy
Bonnie S Glisson
Fadlo R Khuri
Gary Frenette
P304
P356
10.1200/JCO.20.6.1593
P407
P577
2002-03-01T00:00:00Z